Who Paid My Doc
Syed Shahryar
Critical Care Medicine Phoenix, AZ Medical Doctor
NPI 1982613097 CMS profile 43784
3330 N 2Nd St, Suite 300, Phoenix, AZ 85012
General payments
$19,832
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Syed Shahryar of Phoenix, AZ is reported in the CMS Open Payments database as having received $19,832 across 36 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $61 | 1 | |
| 2023 | General | $90 | 1 | |
| 2022 | General | $4,638 | 4 | |
| 2021 | General | $6,069 | 14 | |
| 2019 | General | $8,974 | 16 |
Beside peers
- Syed Shahryar
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Syed Shahryar were reported at $0. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Syed Shahryar | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,974 | $149 | $51–$535 | $163 |
| 2020 | $0 | $110 | $30–$325 | $114 |
| 2021 | $6,069 | $125 | $34–$403 | $132 |
| 2022 | $4,638 | $157 | $49–$582 | $149 |
| 2023 | $90 | $162 | $56–$621 | $160 |
| 2024 | $61 | $168 | $53–$634 | $164 |
| 2025 | $0 | $189 | $59–$844 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 12 billing codesPaid by Medicare
$41,520
Medicare patients
90
Services billed
286
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Heart failure | 75% | |
| Ischemic heart disease | 67% | |
| Diabetes | 66% | |
| Chronic kidney disease | 59% | |
| Atrial fibrillation | 54% | |
| COPD | 49% | |
| Arthritis | 43% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
36 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in Arizona
Naomi Habib
Critical Care Medicine · Phoenix, AZ
Douglas Mapel
Critical Care Medicine · Prescott, AZ
Akshay Muralidhar
Critical Care Medicine · Scottsdale, AZ
Rodrigo Cartin-Ceba
Critical Care Medicine · Scottsdale, AZ
Robert Matheny
Critical Care Medicine · Kingman, AZ
Reena Bansal
Critical Care Medicine · Scottsdale, AZ
Related records
Critical Care Medicine in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.